These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 11294698

  • 1. Measurement of free and complexed soluble vascular endothelial growth factor receptor, Flt-1, in fluid samples: development and application of two new immunoassays.
    Belgore FM, Blann AD, Lip GY.
    Clin Sci (Lond); 2001 May; 100(5):567-75. PubMed ID: 11294698
    [Abstract] [Full Text] [Related]

  • 2. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
    Lip PL, Belgore F, Blann AD, Hope-Ross MW, Gibson JM, Lip GY.
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
    [Abstract] [Full Text] [Related]

  • 3. Vascular endothelial growth factor and its receptor, Flt-1, in smokers and non-smokers.
    Belgore FM, Lip GY, Blann AD.
    Br J Biomed Sci; 2000 Jul; 57(3):207-13. PubMed ID: 11050771
    [Abstract] [Full Text] [Related]

  • 4. Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes.
    Blann AD, Belgore FM, McCollum CN, Silverman S, Lip PL, Lip GY.
    Clin Sci (Lond); 2002 Feb; 102(2):187-94. PubMed ID: 11834138
    [Abstract] [Full Text] [Related]

  • 5. Plasma levels of vascular endothelial growth factor (VEGF) and its receptor, Flt-1, in haematological cancers: a comparison with breast cancer.
    Belgore FM, Lip GY, Bareford D, Wadley M, Stonelake P, Blann AD.
    Am J Hematol; 2001 Jan; 66(1):59-61. PubMed ID: 11426496
    [Abstract] [Full Text] [Related]

  • 6. Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis.
    Ballara S, Taylor PC, Reusch P, Marmé D, Feldmann M, Maini RN, Paleolog EM.
    Arthritis Rheum; 2001 Sep; 44(9):2055-64. PubMed ID: 11592367
    [Abstract] [Full Text] [Related]

  • 7. Vascular endothelial growth factor and tissue factor in patients with established peripheral artery disease: a link between angiogenesis and thrombogenesis?
    Makin AJ, Chung NA, Silverman SH, Lip GY.
    Clin Sci (Lond); 2003 Apr; 104(4):397-404. PubMed ID: 12653684
    [Abstract] [Full Text] [Related]

  • 8. Soluble FLT-1 is detectable in the sera of colorectal and breast cancer patients.
    Kumar H, Heer K, Greenman J, Kerin MJ, Monson JR.
    Anticancer Res; 2002 Apr; 22(3):1877-80. PubMed ID: 12168886
    [Abstract] [Full Text] [Related]

  • 9. Exercise increases soluble vascular endothelial growth factor receptor-1 (sFlt-1) in circulation of healthy volunteers.
    Bailey AP, Shparago M, Gu JW.
    Med Sci Monit; 2006 Feb; 12(2):CR45-50. PubMed ID: 16449946
    [Abstract] [Full Text] [Related]

  • 10. Soluble vascular endothelial growth factor receptor-1 (sFLT-1) mediates downregulation of FLT-1 and prevents activated neutrophils from women with preeclampsia from additional migration by VEGF.
    Krysiak O, Bretschneider A, Zhong E, Webb J, Hopp H, Verlohren S, Fuhr N, Lanowska M, Nonnenmacher A, Vetter R, Jankowski J, Paul M, Schönfelder G.
    Circ Res; 2005 Dec 09; 97(12):1253-61. PubMed ID: 16269656
    [Abstract] [Full Text] [Related]

  • 11. Soluble vascular endothelial growth factor, soluble VEGF receptor Flt-1 and endothelial function in healthy smokers.
    Schmidt-Lucke C, Belgore F, Reinhold D, Ansorge S, Klein HU, Schmidt-Lucke JA, Lip GY.
    Int J Cardiol; 2005 Apr 20; 100(2):207-12. PubMed ID: 15823626
    [Abstract] [Full Text] [Related]

  • 12. [The relationship between plasma level of VEGF or soluble Flt-1 and efficacy of hepatic arterial chemotherapy in patients with liver metastasis of colorectal cancer].
    Gonda T, Okada N, Nakada H, Yokoyama M, Miyazaki T, Ishibashi K, Ishida H, Matsumoto Y, Miura T.
    Gan To Kagaku Ryoho; 2006 Nov 20; 33(12):1841-4. PubMed ID: 17212123
    [Abstract] [Full Text] [Related]

  • 13. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes.
    Aguayo A, Kantarjian HM, Estey EH, Giles FJ, Verstovsek S, Manshouri T, Gidel C, O'Brien S, Keating MJ, Albitar M.
    Cancer; 2002 Nov 01; 95(9):1923-30. PubMed ID: 12404286
    [Abstract] [Full Text] [Related]

  • 14. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D, Jimenez X, Zhang H, Wu Y, Bohlen P, Witte L, Zhu Z.
    Cancer Res; 2001 Oct 01; 61(19):7002-8. PubMed ID: 11585724
    [Abstract] [Full Text] [Related]

  • 15. Usefulness of soluble Fms-like tyrosine kinase-1 as a biomarker of acute severe heart failure in patients with acute myocardial infarction.
    Onoue K, Uemura S, Takeda Y, Somekawa S, Iwama H, Nishida T, Morikawa Y, Nakagawa H, Tsutsumi T, Sung JH, Takemoto Y, Soeda T, Okayama S, Ishigami K, Kawata H, Horii M, Nakajima T, Saito Y.
    Am J Cardiol; 2009 Dec 01; 104(11):1478-83. PubMed ID: 19932778
    [Abstract] [Full Text] [Related]

  • 16. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?
    George ML, Eccles SA, Tutton MG, Abulafi AM, Swift RI.
    Clin Cancer Res; 2000 Aug 01; 6(8):3147-52. PubMed ID: 10955796
    [Abstract] [Full Text] [Related]

  • 17. Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: a possible diagnostic tool for lymph node metastasis.
    Tamura M, Ohta Y.
    Cancer; 2003 Sep 15; 98(6):1217-22. PubMed ID: 12973845
    [Abstract] [Full Text] [Related]

  • 18. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.
    Park CW, Park JS, Shim SS, Jun JK, Yoon BH, Romero R.
    Am J Obstet Gynecol; 2005 Sep 15; 193(3 Pt 2):984-9. PubMed ID: 16157098
    [Abstract] [Full Text] [Related]

  • 19. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.
    Shang ZJ, Li JR, Li ZB.
    Int J Oral Maxillofac Surg; 2002 Oct 15; 31(5):495-8. PubMed ID: 12418564
    [Abstract] [Full Text] [Related]

  • 20. The fourth immunoglobulin-like loop in the extracellular domain of FLT-1, a VEGF receptor, includes a major heparin-binding site.
    Park M, Lee ST.
    Biochem Biophys Res Commun; 1999 Nov 02; 264(3):730-4. PubMed ID: 10544000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.